Reports
Sale
North America COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product; By Sample Type; By Business Model: Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing; By End Use: Hospitals, Diagnostic Centres and Clinics, Laboratories; By Country (2020-2026); Competitive Landscape, 2024-2032
North America COVID-19 Diagnostics Market Outlook
The North America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed nearly 390 million tests for COVID-19 as of March 2021.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Number of COVID-19 Cases to Propel the Growth of the COVID-19 Diagnostics Industry in the Short Term
Ever since the outbreak of the COVID-19 pandemic, the demand for COVID-19 diagnostic kits has exponentially risen in North America because of the widespread need for testing within the region. The demand for the diagnostic kits have, especially, witnessed a substantial rise in the United States of America due to the significant and rising number of active cases in the country. The highest number of cases in the world have been registered in the United States of America as of March 2021, and there has been a great need for testing and vaccination in the country. To prevent the spread of the virus further, the country has also implemented measures to test travellers entering the country and those travelling within the country, thus, further contributing to the growth of the COVID-19 diagnostics industry in North America.
In the short term, the demand for COVID-19 diagnostics is expected to rise rapidly in the North America region, but in the long term, the market is expected to shrink as vaccines for COVID-19 enter the market and people develop antibodies.
COVID-19 Diagnostics: Market Segmentation
COVID-19 diagnostics are used to detect if a person is COVID-19 positive, their infection level, or if they have developed COVID-19 antibodies. They may involve tests of different types, such as RT PCR test, rapid antigen test, and others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for COVID-19 diagnostics may be divided by test type into:
- PCR Test
- Antigen Test
- Antibody Test
- Others
The market can be segmented on the basis of product into:
- RT-PCR Assay Kits
- Immunoassay Test Strips
- Others
The industry can be differentiated by end use into:
- Hospitals
- Diagnostic Centres and Clinics
- Laboratories
- Others
The market can be further segmented by sample type into:
- Nasopharyngeal Swab
- Oropharyngeal (OP) Swab
- Nasal Swab
- Blood Test
- Others
By business model, the industry can be divided into:
- Point-of-Care (PoC) Testing
- Non-Point-of-Care (PoC) Testing
The regional markets for the COVID-19 diagnostics industry in North America can be divided into Canada and the United States of America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Favourable Governmental Regulations Bolstering the Market Growth in North America
The rising number of novel coronavirus cases in the North America region, especially in the United States of America, has led to a massive demand for testing kits. The portability of these testing kits has allowed more people to be tested in a large number, and it is expected that the demand for these will continue to grow, at least in the short term.
Since there have been multiple waves observed in the prevalence of the transmission of COVID-19, along with mutations of the virus into different variants, the same population has been tested multiple times, causing a consistent demand for the diagnostic tools. Governments in the North America region have relaxed regulations for these diagnostic kits in view of the emergency. Such measures have catalysed the growth of the COVID-19 diagnostics market. There has also been continuous research and development sponsored by both the government and private players, which has helped to create more effective testing kits, with fewer occurrences of false positive reports, further propelling the market ahead.
Key Industry Players in the North America COVID-19 Diagnostics Market
The report gives a detailed analysis of the following key players in the North America COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories
- Becton, Dickinson and Company
- LuminUltra Technologies Ltd.
- Co-Diagnostics, Inc
- CTK Biotech, Inc.
- Thermo Fisher Scientific
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by Sample Type |
|
| Breakup by Business Model |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Regional
7 Industry Opportunities and Challenges
8 North America COVID-19 Overview
8.1 Number of COVID-19 Cases in North America
8.2 North America COVID-19 Cases by Country
8.2.1 United States of America
8.2.2 Canada
9 North America COVID-19 Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 North America COVID-19 Diagnostics Market (2020-2026)
9.3 North America COVID-19 Diagnostics Market by Test Type (2020-2026)
9.3.1 PCR Test
9.3.2 Antigen Test
9.3.3 Antibody Test
9.3.4 Others
9.4 North America COVID-19 Diagnostics Market by Product (2020-2026)
9.4.1 RT-PCR Assay Kits
9.4.2 Immunoassay Test Strips
9.4.3 Others
9.5 North America COVID-19 Diagnostics Market by Sample Type (2020-2026)
9.5.1 Nasopharyngeal Swab
9.5.2 Oropharyngeal (OP) Swab
9.5.3 Nasal Swab
9.5.4 Blood Test
9.5.5 Others
9.6 North America COVID-19 Diagnostics Market by Business Model (2020-2026)
9.6.1 Point-of-Care (PoC) Testing
9.6.2 Non-Point-of-Care (PoC) Testing
9.7 North America COVID-19 Diagnostics Market by End Use (2020-2026)
9.7.1 Hospitals
9.7.2 Diagnostic Centres and Clinics
9.7.3 Laboratories
9.7.4 Others
9.8 North America COVID-19 Diagnostics Market by Country (2020-2026)
9.8.1 United States of America
9.8.2 Canada
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abbott Laboratories
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 LuminUltra Technologies Ltd.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Co-Diagnostics, Inc
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 CTK Biotech, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Thermo Fisher Scientific Inc.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. North America COVID-19 Cases by Country
2. North America COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3. North America COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4. North America COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5. North America COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6. North America COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7. North America COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8. North America COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
9. North America COVID-19 Diagnostics Market Structure
Key Questions Answered in the Report
The North America COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed nearly 390 million tests for COVID-19 as of March 2021.
The major drivers of the industry include the rising occurrence of COVID-19 cases, increasing mutations and variants of the virus, growing investments, and the large population base.
The growing technological improvements in the diagnostic kits and the increasing R&D activities are expected to be the key trends guiding the growth of the industry.
The major regions in the industry are the United States of America and Canada.
The major test types available in the industry are PCR test, antigen test, and antibody test, among others.
The significant products available in the industry are RT-PCR assay kits and immunoassay test strips, among others.
The leading sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.
The major business models in the industry are point-of-care (PoC) testing and non-point-of-care (PoC) testing.
The significant end use sectors in the industry are hospitals, and diagnostic centres and clinics, laboratories, among others.
The leading players in this market are Abbott Laboratories, Becton, Dickinson and Company, LuminUltra Technologies Ltd., Co-Diagnostics, Inc, CTK Biotech, Inc., and Thermo Fisher Scientific, among others.
Analyst Review
The North America COVID-19 diagnostics market is primarily being driven by the high number of COVID-19 positive cases, especially in the United States of America, which performed about 390 million tests for COVID-19 as of March 2021. Aided by government and private collaboration, the industry is expected to witness a further growth in the short term.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. By test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. Based on products, the industry is divided into RT-PCR assay kits and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. Based on business models, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. By end uses, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in North America are the United States of America and Canada. The key players in the above industry include Abbott Laboratories, Becton, Dickinson and Company, LuminUltra Technologies Ltd., Co-Diagnostics, Inc, CTK Biotech, Inc., and Thermo Fisher Scientific, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER